Federal health officials are suggesting that the recent surge in adverse event reports involving bleeding problems with Pradaxa, an anticoagulant that has been linked to thousands of cases involving uncontrollable…
According to a review of adverse event reports submitted to the FDA, Pradaxa bleeding problems appear to be five times more likely to result in death than those associated with…
Bayer, Johnson & Johnson, and Portola Pharmaceuticals indicate that they are planning to collaborate on the development of an antidote for the blood thinner Xarelto, which would allow doctors to…
A federal judge has ruled that during the discovery phase of the Pradaxa litigation, plaintiffs may obtain documents and other materials involving the marketing practices of Boehringer Ingelheim, including information…
Lawyers involved in the federal Pradaxa litigation are expected to begin meeting to discuss possible settlement agreements later this year, as the first lawsuits are being prepared for trials that…
The cancer drugs Nexavar, Sutent and Votrient appear to increase the risk of death among some patients, according to the findings of a new study.
